Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
about
Trimethylamine N-Oxide: The Good, the Bad and the UnknownGut microbiome and kidney disease: a bidirectional relationship.Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patientsElevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function.Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.An overview of renal metabolomics.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.The gut-kidney axis.Targeting the Microbiome in Heart Failure.Inflammation and premature aging in advanced chronic kidney disease.The role of epigenetics in renal ageing.Trimethylamine N-oxide: breathe new life.Gut Microbiota and Atherosclerosis.The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting.Relationship between serum trimethylamine N-oxide and exposure to dioxin-like pollutants.Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.Novel treatment strategies for chronic kidney disease: insights from the animal kingdom.Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.Microbial modulation of cardiovascular disease.Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice.Uremic Toxin Clearance and Cardiovascular Toxicities.Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.The metabolomic quest for a biomarker in chronic kidney disease
P2860
Q28079182-0D5747D0-AEB3-4B31-8AF1-4EA2ECF20F4DQ33586234-6A22CBB2-DC7C-41D0-A071-185FFE1877D0Q33684162-C663EB2A-F02F-4F09-B969-C6444E434A52Q33731986-DC03A6C0-8629-4738-A288-71D021F01F47Q36340545-55740E18-AA56-489D-9D5D-AB0ABFEC3490Q37076037-D2E6C4A3-2BAA-4AD7-9BA1-69A1197B1627Q37630442-44392EC8-9EFC-4469-AF2C-76545F4CA03FQ38636372-D5DBA36F-8CC0-48E2-A690-92FA03276118Q38637363-D3FC3654-6971-4792-8352-3083DCF1058AQ38701617-5D786AE4-D7B8-47D5-AE47-BD9B2320BA70Q38815775-3A242747-57E9-4DBD-8B21-E00239A69688Q38918147-116EEA3E-D5AA-4107-819A-80D73D4A317EQ39009765-660B83BD-428E-43F5-9A3D-96AA16F2FD0DQ39186198-952C11A2-15FD-48EE-9470-5786DEECA989Q39309490-CF67F393-E938-47E2-BAFF-C6EC34547A97Q39381492-2D9436A7-62AB-494C-AE40-2AB5D72857C0Q39459129-F9F441BE-E5A2-483A-98C6-888466D3D577Q40079055-C974D450-2A94-4409-A397-93198F64AB99Q45061812-72EE6F49-527F-4DC7-BE40-A5B7B2C21DE8Q47135542-71382061-9310-4318-8C6A-26C458C9E017Q47167057-58C03C7E-230E-44C1-A8CF-566A8A083DD1Q47343299-1556609D-C213-4836-A5AA-7830024D927AQ47651164-15FD27F0-FCBB-4EEC-953A-23CA4E93A5D4Q48014347-C763FC03-60D9-4391-B01A-A8CDC9F95CC8Q50051044-81162071-D278-415D-A354-C72912D0BA8DQ50094276-A12F13DD-9101-4E99-A692-FB65E0B9E275Q50144047-F0E0D4BE-76C0-49C9-85D7-18CC4E743B83Q51732046-7A1124C1-FE89-495C-975D-6B498A1F5B05Q53684068-4839E7CA-AC5F-4F7A-8E10-4B05E040C8B9Q55473173-DBA51030-0109-4252-A66F-0961074CAA92Q55496554-F892EABB-D88D-417D-9DF0-EE4E3D112D87Q57053846-4A4E0A4D-0FDC-4DA5-81EF-748B5F2C96FA
P2860
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Serum Trimethylamine-N-Oxide I ...... come in Chronic Kidney Disease
@ast
Serum Trimethylamine-N-Oxide I ...... come in Chronic Kidney Disease
@en
type
label
Serum Trimethylamine-N-Oxide I ...... come in Chronic Kidney Disease
@ast
Serum Trimethylamine-N-Oxide I ...... come in Chronic Kidney Disease
@en
prefLabel
Serum Trimethylamine-N-Oxide I ...... come in Chronic Kidney Disease
@ast
Serum Trimethylamine-N-Oxide I ...... come in Chronic Kidney Disease
@en
P2093
P2860
P50
P1433
P1476
Serum Trimethylamine-N-Oxide I ...... come in Chronic Kidney Disease
@en
P2093
Abdel Rashid Qureshi
Catharina Missailidis
Jenny Hällqvist
Peter Barany
Peter Bergman
P2860
P304
P356
10.1371/JOURNAL.PONE.0141738
P407
P577
2016-01-11T00:00:00Z